DIA-Based Proteomics Identifies IDH2 as a Targetable Regulator of Acquired Drug Resistance in Chronic Myeloid Leukemia
Author:
Publisher
Elsevier BV
Subject
Molecular Biology,Biochemistry,Analytical Chemistry
Reference73 articles.
1. Donor lymphocyte infusions for chronic myeloid leukemia relapsing after allogeneic stem cell transplantation: May we predict graft-versus-leukemia without graft-versus-host disease?;Radujkovic;Biol. Blood Marrow Transpl.,2015
2. Chronic myeloid leukemia, version 1.2019, NCCN clinical practice guidelines in oncology;Radich;J. Natl. Compr. Canc. Netw.,2018
3. Clinical cancer advances 2019: Annual report on progress against cancer from the American Society of Clinical Oncology;Pal;J. Clin. Oncol.,2019
4. The different mechanisms of cancer drug resistance: A brief review;Mansoori;Adv. Pharm. Bull.,2017
5. Targeting P-glycoprotein: Nelfinavir reverses adriamycin resistance in K562/ADR cells;Liu;Cell Physiol. Biochem.,2018
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Transcriptome and single-cell transcriptomics reveal prognostic value and potential mechanism of anoikis in skin cutaneous melanoma;Discover Oncology;2024-03-09
2. VARIDT 3.0: the phenotypic and regulatory variability of drug transporter;Nucleic Acids Research;2023-10-11
3. IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer;The EMBO Journal;2023-01-13
4. Sustained activation of non-canonical NF-κB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL;Leukemia;2022-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3